Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
RJ Bio-Tech Ltd.
BSE Code 536456
ISIN Demat INE594O01015
Book Value (Rs) 0.00
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 32.47
TTM PE(x) 0.00
TTM EPS(Rs) -4.28
Face Value (Rs) 10  
Particulars Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Operational & Financial Ratios          
   Earnings Per Share (Rs)-4.28  -16.56  -4.39  -12.18  -21.93  
   CEPS(Rs)-4.21  -16.47  -4.29  -12.02  -21.74  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-53.17  -43.50  -28.10  -23.63  -11.50  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)9.46  -79.89  -26.02  -72.94  -90.00  
   EBIT Margin(%)12.76  -99.26  -25.19  -73.08  -189.91  
   Pre Tax Margin(%)-29.14  -99.28  -31.06  -113.98  -233.67  
   PAT Margin (%)-29.14  -99.28  -31.06  -113.98  -233.67  
   Cash Profit Margin (%)-28.65  -98.70  -30.33  -112.50  -231.55  
Performance Ratios          
   ROA(%)-104.09  -100.28  -15.63  -36.69  -50.28  
   ROE(%)0.00  0.00  0.00  0.00  0.00  
   ROCE(%)0.00  -218.35  -19.75  -32.76  -51.57  
   Asset Turnover(x)3.57  1.01  0.50  0.32  0.22  
   Sales/Fixed Asset(x)3.08  3.49  3.02  2.31  2.02  
   Working Capital/Sales(x)-0.29  -0.40  -0.58  -0.54  -1.18  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.32  0.29  0.33  0.43  0.50  
   Receivable days14.52  94.72  237.13  480.92  731.32  
   Inventory Days0.00  179.09  380.60  491.48  761.77  
   Payable days18.67  40.89  161.00  173.18  122.42  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-1.23  -0.41  -3.01  -1.61  -1.13  
   Price/Book(x)-0.10  -0.15  -0.46  -0.82  -2.13  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)4.00  2.95  4.05  5.88  6.82  
   EV/Core EBITDA(x)27.91  -3.69  -16.05  -8.22  -7.68  
   EV/EBIT(x)31.32  -2.97  -16.04  -8.05  -3.57  
   EV/CE(x)28.94  7.95  2.13  2.14  1.72  
   M Cap / Sales0.35  0.40  0.91  1.81  2.62  
Growth Ratio          
   Net Sales Growth(%)-12.02  18.24  32.06  14.35  -43.75  
   Core EBITDA Growth(%)115.76  -274.68  53.51  7.81  30.25  
   EBIT Growth(%)111.31  -365.06  54.40  56.20  -47.87  
   PAT Growth(%)74.18  -277.31  63.95  44.47  -38.29  
   EPS Growth(%)74.18  -277.31  63.95  44.47  -38.29  
Financial Stability Ratios          
   Total Debt/Equity(x)-1.01  -0.98  -1.57  -1.84  -3.41  
   Current Ratio(x)0.01  0.09  0.49  0.56  0.81  
   Quick Ratio(x)0.01  0.06  0.17  0.25  0.46  
   Interest Cover(x)0.30  -6943.08  -4.30  -1.79  -4.34  
   Total Debt/Mcap(x)10.35  6.32  3.43  2.26  1.60